top of page
News

Search


University of Calgary research team has discovered a groundbreaking method for transforming limestone into a bacteria-killing nanoparticle
Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles. Biosenta Inc. announced that two independent, peer-reviewed studies confirmed that its proprietary Tri-Fillerâ„¢ nanoparticles achieved complete (100%) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides.
7 days ago1 min read
3 views


Biosenta’s Tri‑Filler™ Nanoparticles Achieve 100% killing of Pathogens at Industry‑Low Dose in Peer‑Reviewed Studies
Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles. Biosenta Inc. announced that two independent, peer-reviewed studies confirmed that its proprietary Tri-Fillerâ„¢ nanoparticles achieved complete (100%) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides.
7 days ago4 min read
7 views


UCalgary research team discovers novel method for transforming limestone into a bacteria-killing nanoparticle
A University of Calgary research team, partnered with Biosenta Inc., has developed a method to transform limestone into a long-lasting antimicrobial nanoparticle. This new "shell and core" technology has a durable active ingredient, calcium hydroxide, and has been proven effective against various harmful pathogens. Potential applications include enhancing concrete, paint for healthcare settings, and coatings for food packaging and high-touch surfaces.
Jun 101 min read
12 views


Revolutionizing the material world: Tackling the antimicrobial health crisis
Kris Hans shares how Biosenta is tackling the antimicrobial health crisis at the source, and why this work matters now more than ever.
Apr 71 min read
20 views


Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability.
Jun 13, 20241 min read
79 views


Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Biosenta announces significant advancements at its state-of-the-art bench scale production facility.
Jun 10, 20243 min read
41 views


Breakout Antimicrobial Biotechnology Quietly Building Success
Biosenta has been making the innovative strides in the realm of antimicrobial biotechnology.
Jun 5, 20241 min read
32 views


The Watchlist: Biosenta Inc. announces licensing agreement
Biosenta Inc. announces licensing agreement
May 10, 20240 min read
39 views


Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Fillerâ„¢ Particle Encapsulation Technology
Biosenta announces technological and operational advancements with successful construction and operation of a bench scale production plant.
Mar 27, 20242 min read
15 views


Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillerâ„¢
Biosenta announces a pivotal discovery revealed that Tri-Fillerâ„¢ effectively sterilizes a wide range of microorganisms.
Sep 28, 20235 min read
49 views


Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta will test Tri-Fillerâ„¢ in plastics at AMPAK Inc. facilities with an eye to commercialization.
Sep 8, 20230 min read
52 views


Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta will test Tri-Fillerâ„¢ in plastics at AMPAK Inc. facilities with an eye to commercialization.
Sep 6, 20234 min read
50 views


Biosenta Inc. announces further advances in research and development of Tri-Fillerâ„¢
Biosenta Inc. announces further advances in research and development of Tri-Fillerâ„¢
Aug 12, 20231 min read
41 views


Solution fighting a drug-resistant fungus in hospitals of U.S. and Canada
UoC professor taking about a solution fighting a drug-resistant fungus that has become a big issue for hospitals in the U.S. and Canada.
Aug 11, 20231 min read
24 views


Biosenta announces further advances in research and development of Tri-Fillerâ„¢
Biosenta Inc. announces further advances in research and development of the Tri-Fillerâ„¢ particle.
Aug 8, 20235 min read
108 views


Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.
Biosenta Inc. announces that it has ceased negotiations with Voran Group Ventures Ltd.
May 31, 20231 min read
49 views


Summit-bound CEO sees promising future for Edmonton region
Chelsey Reschke is one of 47 Canadians attending the G20 Young Entrepreneurs’ Alliance summit in Hamburg from Oct. 27 to 28.
Oct 26, 20221 min read
82 views


Biosenta Inc. enters into an MOU with Voran Group Ventures Ltd.
Biosenta Inc. has signed an MOU with Voran Group Ventures Ltd. for the commercialization of Biosenta’s Tri-Filler® antimicrobial products.
Oct 18, 20223 min read
77 views


University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
May 26, 20223 min read
47 views


09/24/2020 - Biosenta and University of Calgary enter into a four year partnership
This partnership enables the University team to research nanoparticles for use as antimicrobial filler in commercial construction materials.
Sep 24, 20203 min read
129 views
bottom of page